Boston Scientific (BSX) Capital Expenditures Growth (1y) (2010 - 2026)
Powered by 
Analysis
Boston Scientific (BSX) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -6.52% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 8.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.20% |
| Mar 31, 2026 | -5.35% |
| Dec 31, 2025 | 26.71% |
| Sep 30, 2025 | 1.12% |
| Jun 30, 2025 | 1.29% |
| Mar 31, 2025 | 4.47% |
| Dec 31, 2024 | 3.75% |
| Sep 30, 2024 | -5.79% |
| Jun 30, 2024 | 8.39% |
| Mar 31, 2024 | 61.26% |
| Dec 31, 2023 | 25.94% |
| Sep 30, 2023 | 26.67% |
| Jun 30, 2023 | 36.19% |
| Mar 31, 2023 | -8.26% |
| Dec 31, 2022 | -20.30% |
| Sep 30, 2022 | 40.19% |
| Jun 30, 2022 | -0.94% |
| Mar 31, 2022 | 61.33% |
| Dec 31, 2021 | 67.30% |
| Sep 30, 2021 | 118.37% |